Finishing chemotherapy does not always mean getting your energy back. Fatigue can linger alongside poor sleep and low mood, making even a reassuring follow-up visit feel incomplete. Self-acupressure is worth examining here: a structured practice using finger pressure, without needles, that someone can learn and use at home.
Evidence at a glance
Population: mainly women with early-stage breast cancer after treatment. Intervention: taught, daily self-acupressure—not acupuncture. Signal: improved fatigue compared with usual care. Limits: small or unblinded comparisons, selected populations and incomplete separation from sham treatment. Boundary: symptom support, not evidence of cancer control.
The earlier trial: a clinically relevant difference
A 2016 randomized trial assigned 288 women with stage 0–III breast cancer, at least a year after completing cancer treatment, to relaxing acupressure, stimulating acupressure or usual care. The practice was performed daily for six weeks.
Among participants assessed at six weeks, 66.2% in the relaxing group and 60.9% in the stimulating group had fatigue scores below the study’s clinically relevant threshold, compared with 31.3% receiving usual care. For relaxing acupressure, that is about 35 percentage points more—not merely a small numerical change.
The two active approaches did not differ significantly. There was no sham-pressure group, and missing follow-up data matter: these percentages do not describe every randomized participant. Attention, expectation and taking regular time for self-care could contribute.
What changed in September 2026?
A trial published September 17, 2026 randomized 108 breast cancer survivors in China to true acupressure, light pressure at non-acupoints, or usual care. Participants had stage I–IIIa disease and persistent fatigue, sleep disturbance and depressive symptoms after chemotherapy.
Both pressure groups received training and practiced 36 minutes daily for seven weeks; 93 participants completed the study. True acupressure improved the combined symptom burden more than either comparator at weeks seven and nineteen. But fatigue alone was not significantly better than sham immediately after treatment; that difference appeared at week nineteen. No adverse events were reported.
That distinction matters. The findings are encouraging, but they do not establish a reliable individual response or broad applicability during chemotherapy. A demanding daily routine, a selected population and follow-up limited to nineteen weeks also constrain the conclusion.
Where it fits—and what to check first
The 2024 ASCO–SIO fatigue guideline, which predates the newer study, conditionally supports acupressure after cancer treatment, with low-certainty evidence. Exercise, cognitive behavioral therapy and mindfulness-based programs have stronger recommendations. Acupressure can sit alongside those options; it need not displace them.
Fatigue still deserves assessment for contributing problems such as anemia, pain, poor sleep, nutrition difficulties and medication effects. A symptom-management practice should not become a reason to overlook a treatable cause.
Noninvasive is not the same as harmless: one participant in the 2016 trial withdrew because of bruising. Ask for instruction adapted to your surgery, skin health and bleeding risk. Avoid painful or injured areas, stop if pressure causes bruising or worsening symptoms, and have the team review any concerns before starting.
Questions for the care team
- Does my fatigue need further medical evaluation?
- Can someone teach a protocol studied in breast cancer survivors and adapt it safely?
- Is this daily time commitment realistic alongside exercise, sleep care and other support?
- What change in fatigue or everyday function would make this worthwhile, and when should we reassess?
Evidence checked October 14, 2026. Educational review; research doses and schedules are not personal prescriptions. Explore the Missing Script article library and the podcast—coming soon.
